Description
dihexa clinical trials or human studies research Dose:50 mg evidence:limited bpc-157 – peptide interaction studies Size:50mg BPC-157 10mg Vial -
BPC-157 10mg Vial - Mesilla Valley Pharmacy
At Lifeline Primary Care, your safety and comfort are our top priorities
peptide interaction studies
Size:50mg
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since